Literature DB >> 2121145

Overexpression of the CDC25 gene, an upstream element of the RAS/adenylyl cyclase pathway in Saccharomyces cerevisiae, allows immunological identification and characterization of its gene product.

M Vanoni1, M Vavassori, G Frascotti, E Martegani, L Alberghina.   

Abstract

The product of the START gene CDC25, an upstream element of the RAS/adenylyl cyclase pathway in Saccharomyces cerevisiae, was identified using specific antibodies raised against a chimeric beta-galactosidase/CDC25 protein. The CDC25 protein is poorly expressed and can be detected only when the CDC25 gene is overexpressed under the control of the galactose-inducible GAL1-10 strong promoter elements. It has a molecular weight of 180,000, is not glycosylated and is strongly associated with the particulate fraction. After deletion of residues 1255-1550 the protein is found in the soluble fraction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121145     DOI: 10.1016/s0006-291x(05)80173-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  TFS1: a suppressor of cdc25 mutations in Saccharomyces cerevisiae.

Authors:  L C Robinson; K Tatchell
Journal:  Mol Gen Genet       Date:  1991-11

2.  Anti-Cdc25 antibodies inhibit guanyl nucleotide-dependent adenylyl cyclase of Saccharomyces cerevisiae and cross-react with a 150-kilodalton mammalian protein.

Authors:  E Gross; I Marbach; D Engelberg; M Segal; G Simchen; A Levitzki
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

3.  The CDC25 protein of Saccharomyces cerevisiae promotes exchange of guanine nucleotides bound to ras.

Authors:  S Jones; M L Vignais; J R Broach
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

4.  Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator.

Authors:  E Martegani; M Vanoni; R Zippel; P Coccetti; R Brambilla; C Ferrari; E Sturani; L Alberghina
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.